Last reviewed · How we verify
NCT06780540: Operatie Alert
Testing and Evaluating a Psychoeducation Tool and Guidelines for Victims of Violence in Belgian Hospitals.
NA trial testing Operation Alert: Support prgram in Enhance Care to Victims of Violence in 600 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 600 |
| Start date | 24 August 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 10 locations across Belgium |
Drugs / interventions tested
- Operation Alert: Support prgram
Conditions studied
- Enhance Care to Victims of Violence — all drugs for Enhance Care to Victims of Violence →
Sponsor
University Hospital, Ghent
Who can join
16 and older, any sex, with Enhance Care to Victims of Violence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "Operation Alert/Operatie Alert/Opération Alerte" project, developed by UGent-ICRH and UZGent with funding from the Belgian Federal Public Service for Health, focuses on strengthening basic competencies to better and more quickly identify signs of violence. It also aims to provide victim-centered care and refer to specialized services when necessary. This initiative combines training for healthcare providers with practical tools, such as a psycho-education tool and clinical guidelines, to enhance care delivery. Below is an overview of the project's main components: Sub-Study 1: Psycho-education Tool * Objective: Develop and evaluate a tool to support healthcare providers and patients in understanding and addressing sexual and domestic violence, trauma, and their impacts on well-being. * Tool Description: A set of cards presented in a calendar format, featuring illustrations on one side and explanatory text on the other. Target Groups: Healthcare providers and victims/patients. * Development process: The tool was developed based on literature and input from experts and stakeholders during regular meetings. * Testing Phase: The tool will undergo a pilot study in selected hospitals and non-profit organizations (NGOs) working with victims of violence. * Evaluation: The tool's acceptability, usability, and relevance to the recovery process will be assessed through feedback collected via questionnaires from both healthcare providers and victims/patients. Sub-Study 2: Guidelines Older Adults * Objective: Develop and implement guidelines for screening violence among older adults and providing appropriate care for victims of various forms of violence (psychological, physical, (socio-)economic, and sexual). * Tool Description: A guideline that includes a screening protocol, care and referral pathways, and theoretical background on the topic. * Target Group: Older adults with sufficient cognitive abilities. * Development Process: The guidelines are informed by a literature review, expert, and stakeholder input through regular meetings and focus groups, and a pilot study involving cognitively capable older adults in the geriatric departments of four hospitals. * Testing Phase: The screening protocol is integrated into standard care procedures, such as intake interviews or geriatric assessments. It is implemented by multidisciplinary professionals, including physicians, nurses, psychologists, occupational therapists, and social workers. * Evaluation: Feedback on the guidelines is collected from healthcare providers via questionnaires. Older adults themselves are not directly involved in the evaluation, as the screening protocol is intentionally embedded discreetly within standard care procedures. Training and Support The project includes a robust training component delivered through educational online modules designed to equip healthcare providers with the knowledge and skills necessary to effectively use the tools and guidelines developed. Languages and Application The study materials and procedures are conducted in both French and Dutch, reflecting Belgium's bilingual context. Significance This project highlights the importance of tailored support for victims of violence and a systematic approach to care within clinical settings.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Screening and Caring for Older Adults Affected by Sexual or Other Types of Violence: A Pilot Study at Three Belgian Geriatric Departments.
Boven C, Nobels A, Berg N, Van Den Noortgate N, et al · · 2025 · PMID 41516947 · DOI 10.3390/healthcare14010016
Verify or expand the search:
- PubMed search for NCT06780540
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06780540 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 10 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06780540.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing